Purpose
Methods
Results
Conclusion
Level of Evidence
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ArthroscopyReferences
- Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity.Arthritis Care Res (Hoboken). 2016; 68: 1743-1750
- Osteoarthritis year in review 2017: clinical.Osteoarthritis and cartilage. 2018; 26: 319-325
- Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls.Clinicoecon Outcomes Res. 2021; 13: 421-435
- Platelet-Rich Plasma Versus Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Meta-analysis of 26 Randomized Controlled Trials.Arthroscopy. 2021; 37: 309-325
- Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.Ann Intern Med. 2015; 162: 46-54
- Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis : A prospective randomized controlled study.Orthopade. 2019; 48: 239-247
- Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Safe as We Thought?.Radiology. 2019; 293: 656-663
- Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis.Musculoskelet Surg. 2017; 101: 45-49
- Corticosteroids and Hyaluronic Acid Injections.Clin Sports Med. 2019; 38: 1-15
- The efficacy of intra-articular hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions.Am J Sports Med. 2009; 37: 720-726
- Augmentation Strategies following the Microfracture Technique for Repair of Focal Chondral Defects.Cartilage. 2010; 1: 145-152
- Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial.BMC Musculoskelet Disord. 2011; 12: 195
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.PLoS Med. 2009; 6e1000097
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.BMJ. 2011; 343 (d5928-d5928)
- Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease.Journal of Shoulder and Elbow Surgery. 2009; 18: 927-932
- What is the Minimum Clinically Important Difference for the WOMAC Index After TKA?.Clin Orthop Relat Res. 2018; 476: 2005-2014
- Defining the "Substantial Clinical Benefit" After Arthroscopic Treatment of Femoroacetabular Impingement.Am J Sports Med. 2017; 45: 1297-1303
- Minimal Clinically Important Difference and Substantial Clinical Benefit Values for the 12-Item International Hip Outcome Tool.Arthroscopy. 2019; 35: 411-416
- Clinically Meaningful Improvements After Hip Arthroscopy for Femoroacetabular Impingement in Adolescent and Young Adult Patients Regardless of Gender.J Pediatr Orthop. 2018; 38: 465-470
- Defining the Clinically Meaningful Outcomes for Arthroscopic Treatment of Femoroacetabular Impingement Syndrome at Minimum 10-Year Follow-up: The Timing of Surgery Is Crucial.Orthopaedic Journal of Sports Medicine. 2021; 9 (2325967120985140)
- Clinimetrics Corner: The Minimal Clinically Important Change Score (MCID): A Necessary Pretense.J Man Manip Ther. 2008; 16: E82-83
- Establishing maximum medical improvement following reverse total shoulder arthroplasty for rotator cuff deficiency.Journal of Shoulder and Elbow Surgery. 2018; 27: 1721-1731
- Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.JAMA. 2018; 320: 2564-2579
- Comparative Effect between Infiltration of Platelet-rich Plasma and the Use of Corticosteroids in the Treatment of Knee Osteoarthritis: A Prospective and Randomized Clinical Trial.Rev Bras Ortop (Sao Paulo). 2020; 55: 551-556
- Efficacy of Intra-articular Platelet-Rich Plasma Injections in Knee Osteoarthritis: A Systematic Review.Arthroscopy. 2016; 32: 495-505
- Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis.Am J Sports Med. 2016; 44: 792-800
- Intra-articular corticosteroid for knee osteoarthritis.Cochrane Database of Systematic Reviews. 2015;
- Efficacy and Treatment Response of Intra-articular Corticosteroid Injections in Patients With Symptomatic Knee Osteoarthritis.JAAOS - Journal of the American Academy of Orthopaedic Surgeons. 2017; 25: 703-714
- Impact of Clinical Practice Guidelines on Use of Intra-Articular Hyaluronic Acid and Corticosteroid Injections for Knee Osteoarthritis.JBJS. 2018; 100: 827-834
- Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice.Arthritis Care Res (Hoboken). 2017; 69: 1287-1296
- High and low molecular weight hyaluronic acid differentially influence macrophage activation.ACS Biomater Sci Eng. 2015; 1: 481-493
- High- Versus Low-Molecular-Weight Hyaluronic Acid for the Treatment of Rotator Cuff Tendinopathy: A Triple-Blind Randomized Comparative Trial.Ann Pharmacother. 2021; (1060028021994297)
- The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials.J Orthop Surg Res. 2017; 12: 16
- Platelet-Rich Plasma.Phys Med Rehabil Clin N Am. 2016; 27: 825-853
- Intra-Articular Mesenchymal Stromal Cell Injections Are No Different From Placebo in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Arthroscopy. 2021; 37: 340-358
Article info
Publication history
Footnotes
The authors report the following potential conflicts of interest or sources of funding: L.M.J. reports grants from Arthrex, Mitek, and Smith & Nephew. K.A.C. reports personal fees from Samumed. E.J.S. reports grants from Arthrex, Smith & Nephew, Cartiheal, Fidea, and Organogenesis; personal fees from Fideia, Flexion Therapeutics, JRF, Organogeneisis, Subchondral Solutions, and Vericel; other from Better PT. Full ICMJE author disclosure forms are available for this article online, as supplementary material.